会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Process for the Preparation of Telithromycin
    • 制备泰利霉素的方法
    • US20070260066A1
    • 2007-11-08
    • US10591889
    • 2005-04-25
    • Suhas SohaniMandar DeodharNishant PatelManish PatelMahesh DavadraVinodhamar Kansal
    • Suhas SohaniMandar DeodharNishant PatelManish PatelMahesh DavadraVinodhamar Kansal
    • C07D233/90C07D401/02
    • C07H17/00C07H17/08
    • The present invention relates to the process for the preparation of compounds of formula (I) or its pharmaceutically acceptable salts Formula I The novel compounds (i) 10,11-Anhydro-2′,4″-di-O-benzoyl-12-O-imidazolylcarbonyl-6-O-methylerythromycin A of formula (Xa) Formula (Xa) (ii) 2′,4″-di-O-benzoyl-11-amino-11-N-[4-[4-(3-pyridyl)imidazol-1-yl]butyl]-11-deoxy-6-O-methylerythromycin A 11,12-cyclic carbamate of formula (XIa) Formula (XIa) (iii) 2′-O-benzoyl-11-amino-11-N-[4-[4-(3-pyridyl)imidazol-1-yl]butyl]-11-deoxy-5-O-desosaminyl-6-O-methylerythronolide A 11,12-cyclic carbamate of formula (XIIa) Formula (XIIa) (iv) 2′-benzoyl-11-amino-11-N-[4-[4-(3-pyridyl)imidazol-1-yl]butyl]-11-deoxy-5-O-desosaminyl-6-O-methylerythronolide A 11,12-cyclic carbamate of formula (XIIa) Formula (XIIa) and their use as intermediates in formation of compound of Formula I. Also the process of preparation of compound of formula (XIIIa). Formula (XIIIa)
    • 本发明涉及制备式(I)化合物或其药学上可接受的盐的方法。式I化合物(i)10,11-脱氢-2',4“ - 二-O-苯甲酰基-12 (Xa)式(Xa)(ii)2',4“ - 二-O-苯甲酰基-11-氨基-11-N- [4- [4-(4-甲氧基羰基) (3-吡啶基)咪唑-1-基]丁基] -11-脱氧-6-O-甲基红霉素将式(XIa)的11,12-环状氨基甲酸酯式(XIa)(iii)2'-O-苯甲酰基-11 - 氨基-11-N- [4- [4-(3-吡啶基)咪唑-1-基]丁基] -11-脱氧-5-O-去氨基甲酰基-6-O-甲基红霉内酯将11,12-环状氨基甲酸酯 (XIIa)(XIIa)(ⅳ)2'-苯甲酰基-11-氨基-11-N- [4- [4-(3-吡啶基)咪唑-1-基]丁基] -11-脱氧-5- 式(XIIa)式(XIIa)的O-十二烷基-6-O-甲基红霉内酯A 11,12-环状氨基甲酸酯及其作为形成式I化合物的中间体的用途。另外,式(XIIIa)化合物的制备方法, 。 式(XIIIa)